Choledochal cyst in children in dakar: Diagnostic and therapeutic aspects

Ndeye Aby Ndoye1, Ibrahima Bocar Wellé2, Lissoune Cissé2

  • 1Department of Pediatric Surgery, Albert Royer Children's Hospital; Cheikh Anta Diop University, Dakar, Senegal.

Insights

Choledochal cyst (bile duct cyst) diagnosis and management in children were studied in Dakar. Surgical intervention, primarily excision with hepatico-jejunal anastomosis, proved effective with no mortality, highlighting the importance of prompt diagnosis and treatment.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Medical Imaging

Background:

  • Choledochal cyst (bile duct cyst) is a rare congenital malformation predominantly affecting female children.
  • Early diagnosis and management are crucial for preventing complications such as biliary cirrhosis and malignancy.

Purpose of the Study:

  • To describe the diagnostic, therapeutic, and evolutionary features of bile duct cysts in pediatric patients in Dakar.
  • To evaluate the outcomes of surgical management for choledochal cysts in a West African setting.

Main Methods:

  • A prospective, single-center descriptive study was conducted over three years (2016-2019) at Albert Royer Children's Hospital, Dakar.
  • Ten pediatric patients diagnosed with choledochal cysts were included, with data collection encompassing clinical, biological, radiological, and therapeutic aspects.
  • Imaging modalities, including ultrasound and CT scans, were utilized for diagnosis and classification according to the Todani system.

Main Results:

  • Abdominal pain and vomiting were the most common presenting symptoms, with two patients exhibiting the classic triad of pain, mass, and jaundice.
  • Biological cholestasis was observed in six patients, and cytolysis in five.
  • The majority of cysts were classified as Todani Types 1 and 4. Surgical treatment involved total cyst excision and hepatico-jejunal anastomosis in nine patients; one underwent cyst drainage.
  • Two patients experienced post-operative complications (anastomotic leak, evisceration) but achieved good outcomes after surgical repair. No mortality was recorded.

Conclusions:

  • Choledochal cyst dilatation (CCD) should be suspected in neonates presenting with gastrointestinal symptoms, potentially with jaundice.
  • A combination of ultrasound and CT scans is effective for diagnosing CCD and determining the appropriate Todani classification.
  • Laparotomy remains a valuable surgical approach for managing choledochal cysts, particularly in resource-limited settings like Dakar.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
149
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
1.2K
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
192
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
265